DACLATASVIR for Hepatitis b: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 9 adverse event reports in the FDA FAERS database where DACLATASVIR was used for Hepatitis b.
Most Reported Side Effects for DACLATASVIR
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Fatigue | 510 | 9.1% | 35 | 48 |
| Hepatocellular carcinoma | 419 | 7.5% | 71 | 126 |
| Headache | 411 | 7.3% | 28 | 59 |
| Hepatitis c | 400 | 7.1% | 6 | 29 |
| Drug ineffective | 385 | 6.9% | 8 | 23 |
| Treatment failure | 310 | 5.5% | 5 | 15 |
| Nausea | 287 | 5.1% | 33 | 71 |
| Anaemia | 251 | 4.5% | 42 | 108 |
| Ascites | 205 | 3.7% | 40 | 115 |
| Off label use | 199 | 3.6% | 9 | 72 |
| Insomnia | 183 | 3.3% | 12 | 26 |
| Diarrhoea | 177 | 3.2% | 24 | 49 |
| Hepatic failure | 170 | 3.0% | 86 | 65 |
| Hepatic encephalopathy | 165 | 3.0% | 48 | 101 |
| Genotype drug resistance test positive | 164 | 2.9% | 1 | 4 |
Other Indications for DACLATASVIR
Hepatitis c (2,520)
Chronic hepatitis c (2,063)
Product used for unknown indication (613)
Hepatic cirrhosis (140)
Hepatitis c virus test (84)
Hepatitis c virus test positive (31)
Hiv infection (31)
Hepatocellular carcinoma (25)
Hepatitis (21)
Chronic hepatitis (19)
Other Drugs Used for Hepatitis b
TENOFOVIR DISOPROXIL (2,088)
ENTECAVIR (1,583)
LAMIVUDINE (1,057)
TENOFOVIR ALAFENAMIDE (935)
ADEFOVIR DIPIVOXIL (792)
EMTRICITABINE\TENOFOVIR DISOPROXIL (301)
TENOFOVIR (200)
PEGINTERFERON ALFA-2A (166)
TELBIVUDINE (111)
GLECAPREVIR\PIBRENTASVIR (98)